Summary: We review recent advances toward a comprehensive mathematical theory of T-cell immunity. A key insight is that the efficacy of the T-cell response is best analyzed in terms of T-cell receptor (TCR) avidity and the distribution of this avidity across the TCR repertoire (the 'avidity spectrum'). Modification of this avidity spectrum by a wide range of tuning and tolerance mechanisms allows the system to adapt cross-reactivity and specificity to the challenge at hand while avoiding inappropriate responses against non-pathogenic cells and tissues. Theoretical models relate molecular kinetic parameters and cellular properties to systemic level statistics such as avidity spectra. Such bridge equations are crucial for rational clinical manipulation of T cells at the molecular level.
Introduction
Because of the pathogens' diversity and rapid evolution, the T-cell immune system cannot anticipate precisely which epitopes will be encountered during future pathogenic challenges. Instead, the T-cell system relies on a vast repertoire of different T-cell antigen receptor (TCR) clonotypes that are generated at random in advance, prior to infection. The TCR repertoire comprises millions of clonotypes, a diversity which virtually ensures that at least one T-cell clone will attack a given pathogen (1) (2) (3) (4) . At the same time, the T cells must guard against inappropriate immune responses directed against non-pathogenic proteins (horror autotoxicus).
Here, we review theoretical work that has helped us understand how the T-cell repertoire succeeds in responding to pathogens while remaining non-responsive to the host's own antigens. The recurring theme of this review is that T-cell recognition, rather than being a discrete phenomenon, has to be defined on a continuous scale. The most important consequence is that immune tolerance also becomes a matter of degree. Instead of absolute responsiveness to foreign or 'non-self' antigen and an absolute non-responsiveness to 'self' antigen, it will become apparent that immune tolerance finds a natural place on this continuous scale.
T-cell responsiveness: degenerate and graded or specific and discrete?
One might expect that the requirements of immune fidelity (i.e. reliability, efficacy, and appropriate targeting) are fulfilled by ensuring stringent specificity of TCR antigen recognition, such that each TCR clonotype derives strong stimulation from only one epitope. Recognition would then be a dichotomous, all-or-none phenomenon: appropriate responses could then be ensured simply by removal from the repertoire of TCR clonotypes that recognize non-pathogenic epitopes. However, while clonal deletion of autoreactive cells is a fundamental process in shaping the TCR repertoire (5-7), controlled autoreactivity remains an essential part of the physiology of the immune system (8) , and a plethora of mechanisms is involved in the regulation of T-cell activation (9) (10) (11) (12) (13) . The reason that controlled autoreactivity remains an essential property of T-cell immunity is that stringent specificity is unattainable: it would require an unfeasibly large number of distinct clonotypes (14) . Instead, TCR antigen recognition is degenerate, with each TCR clonotype recognizing, typically with varying strengths, a wide variety of epitopes (15) (16) (17) (18) (19) (20) (21) (22) .
The efficacy of TCR epitope recognition is often described in terms of avidity: a clonotype is said to have high avidity for a given epitope if it is able to respond even when the epitope is present at very low levels, whereas a low-avidity clone requires higher presentation levels (23) (24) (25) . We here review mathematical models of the molecular basis of TCR avidity as well as its role in immunity at the systemic level. Thus, we gain an insight into the central problem of TCR recognition, which is how immune fidelity arises out of TCR degeneracy and controlled autoreactivity.
The TCR recognizes peptide/major histocompatibility complex ligands TCR recognition of antigen ligands takes place in the contact area between a T cell and an antigen-presenting cell (APC) (26) . TCR molecules bind to ligands on the surface of the APC (Fig. 1) . Each ligand molecule consists of a peptide (a protein fragment) attached to a specialized antigen-presenting receptor encoded by the major histocompatibility complex (MHC) of genes. The peptides are generated by cutting up proteins into small fragments (27) . As the size of these peptide fragments increases, the probability that a non-self (pathogen-derived) peptide also occurs in the human self decreases (28) .
Upon binding to a peptide-MHC (pMHC) molecule, transmembrane molecules associated with the TCR acquire the ability to transmit signals to the cellular interior by phosphorylation of intracellular signaling domains associated with the TCR/CD3 complex (29) . This TCR triggering leads to various cellular responses, such as changes in gene expression or the killing of a target cell (30) .
The pMHC ligands found on a single APC form a mixed population of thousands of different species (27, 31) . Most of these are 'harmless', that is derived from host proteins not associated with disease or from non-pathogenic organisms. Probabilistic arguments suggest that TCR repertoire diversity is not constrained by the number of ligands against which the system is protecting but by the within-host diversity of harmless ligands (32) ; the presentation statistics of such ligands is discussed in Box 1.
T-cell efficacy rests on the ability to respond to 'harmful', that is disease-associated, antigens while remaining non-responsive to the harmless background against which these harmful ligands are presented. A key problem in immunology is to understand precisely how the immune system achieves such discrimination. This problem is known as the self-non-self problem, a misleading misnomer because self-derived ligands may be associated with disease, while the body harbors many non-self proteomes that are perfectly harmless and are normally ignored by the immune system (33). The TCR triggering rate as a measure of avidity The signaling strength of a given pMHC species is related to the rate at which it triggers TCR molecules, that is the rate at which TCRs are induced to acquire the ability to transmit intracellular signals during an encounter between a T cell and an APC. A given pMHC ligand triggers TCR molecules at different rates in different clonotypes. Similarly, a TCR of a given clonotype is triggered at different rates by different ligands. The TCR triggering rate per pMHC molecule thus depends on both the clonotype (labeled i) and the ligand species (labeled j). The dependence of the TCR triggering rate on the mean lifetime of a TCR/pMHC interaction is shown in Fig. 2 . The top curve shows that the TCR triggering rate is maximal at an optimal mean TCR/pMHC residence time; this prediction has been experimentally confirmed (34) .
We propose that w ij , the triggering rate elicited in clonotype i by a molecule of pMHC species j, quantitates the avidity of the TCR/pMHC interaction (35) (Box 2). This MHC-specific TCR triggering rate w ij can be measured by a standard bioassay that determines the percentage of T cells of a defined clonotype responding to a range of APCs that have been incubated at various antigen concentrations. The mean residence time T ij can also be experimentally determined; combining the two data, one can deduce the receptor triggering threshold (T R ) (Box 2). Box 2. TCR/pMHC avidity determined by mean residence time and affinity pMHC molecules continually associate and dissociate with TCR molecules in the T cell:APC interface. At equilibrium, the TCR triggering rate per pMHC molecule of species j is given by the following equation:
where we have assumed that a TCR is triggered when the duration of a docking to a pMHC ligand exceeds the receptor threshold T R (80, 81 In our calculations we often use a very simple model in which all these factors are condensed into an aggregate quantity called the presentation propensity (56) . If two ligands have presentation propensities r j and r j# ; respectively, their surface densities are related by
Moreover, we define a ligand's ubiquity u j as the probability that it is presented on the surface of the APC. Different ligands generally have different presentation propensities and ubiquities. Propensity and ubiquity are specific not only for a ligand but also for a class of APCs: thus, the same ligand can have different propensities (and/ or ubiquities) in different classes of APC; see equation 6.2 for an example. Regulated T-cell activation: the responder avidity spectrum An immune response is initiated in the lymphoid organs (lymph nodes and spleen) with the presentation of diseaseassociated pMHC ligands to naive T cells, which constitute the working repertoire of the cellular immune system. Naive T cells interact with professional APCs presenting the relevant ligand from the diseased tissue to the lymphoid organ. Lanzavecchia and Sallusto (36) proposed that a naive T cell is activated when a sufficient number of its TCR molecules are triggered, that is when the rate at which the T cells' TCR molecules are being triggered is above a certain activation threshold which is a cellular property. The activated T cell then commits itself to proliferation and differentiation, leading to the expansion of sufficient numbers of T cells to combat the disease. A combination of models and in vivo data has shown that competition for 'antigenic sites' on APCs is a limiting factor in T-cell expansion (37, 38) .
Only a minute fraction of the naive repertoire is activated (14, 39, 40) : efficient responders exhibit a much higher avidity for the relevant ligand than the general repertoire. This is illustrated in Fig. 3 , which compares the TCR avidity spectrum of the naive repertoire with the TCR avidity spectrum among responding clones: responder spectra are shown for various values of the naive T-cell activation threshold. The TCR avidity spectrum is a statistical distribution (Box 3; Fig. 3 ).
Taken together, the responder spectra in Fig. 3 show that the naive T-cell activation threshold has to be sufficiently high to ensure that there is a significant enrichment of avidity among the responding T cells. In general, there will be 'false positive', lowavidity responders, occurring because of random fluctuations in the population of harmless ligands on the APC, which will occasionally lead to activation even if the T cell has low avidity for the relevant pathogenic ligand. The condition for an effective immune response is that the frequency at which these false positives occur must be much lower than that at which 'true positives' occur. The latter frequency is just the within-repertoire proportion of T cells with high avidity for the relevant ligand. This condition is satisfied if activation thresholds are sufficiently high, as the responder avidity spectra in Fig. 3 demonstrate.
One way to evoke an immune response against a selected antigen is to incubate professional APCs with the antigenic Normalized MHC-specificTCR triggering rate Probability density Fig. 3 . The cellular activation threshold affects avidity spectra among responding clones. The avidity spectrum is the statistical distribution of the TCR triggering rate for a given immunogenic pMHC species j over the population of responding TCR clonotypes i. These responders have been activated by a professional APC bearing the ligand j on its surface. The different curves obtained for various values of the cellular activation threshold. As the threshold increases, the mode (peak) of the distribution shifts to the right. A higher cellular activation threshold thus selects more stringently for high-avidity clones. When this threshold is too low, most of the probability mass is concentrated near 0 (which is also the case, naturally, for the preselection, naive TCR repertoire). Mathematically, the avidity spectrum corresponds to the probability density function dP ÿ w ij T R o i activated by ligand jÞ=do:
MHC-specific TCR triggering rate is a function of mean residence time alone:
See Chan et al. (84) for a discussion of this formula; moreover, the dependence is non-monotone as was predicted on the basis of mechanistic considerations (85) .
The maximum rate (eT R ) ÿ1 is attained at an optimal mean residence time that equals the receptor triggering threshold T R (56) (Fig. 2) , in line with experimental data (34) . The free TCR density in the T cell:APC contact area is determined by the following implicit equation:
where [Z j ] is the surface density of pMHC species j in the T cell:APC contact area, and [R T ] denotes the total TCR density (free plus bound). As the presentation level of a high-affinity ligand increases, the free TCR density decreases and may become lower than the dissociation constant of the ligand. The MHC-specific TCR triggering rate of this ligand then becomes a monotone increasing function of the mean residence time T ij and becomes proportional to the association rate, as shown in Fig. 2 . This predicted shift from a unimodal to a monotone increasing function of the mean residence time T ij was confirmed experimentally (86) . The optimum at T R is restored if [M T ] is sufficiently high and the affinity of the ligand dominates the antigen presentation profile ([M T ] denotes the total (free plus bound) surface density of MHC molecules). In this case, the MHC-specific TCR triggering rate becomes inversely proportional to [M T ], which means that the total contribution made by the ligand ([Z j ]w ij ) is in fact independent of the presentation density [Z j ]. The possibility of presentation levelindependent signaling increases the scope of repertoire selection in the thymus (35) .
van den Berg & Rand Á Quantitative theories of T-cell responsiveness peptide, which is thereby loaded onto the APCs' MHC molecules. Fig. 4 shows predicted avidity spectra among responders for various incubation concentrations. These spectra indicate that progressively less probability mass is concentrated at high avidities as the antigen incubation concentration increases. Thus, we have the perhaps counterintuitive prediction that less efficient responses are to be expected when the antigen is present at higher levels on the APC. This prediction agrees with experimental findings (24, 41) . The need for highavidity responses therefore furnishes an upper bound to the antigen incubation concentration. Selected T cells among the responders differentiate into longlived memory T cells, which ensures a vigorous response to subsequent infections with the same (or a closely related) pathogen (42) . The dynamics of the memory formation affects the long-term evolution of the diversity of the memory T-cell pool, which is crucial in maintaining significant immunity to any given challenge over the long term (43) (44) (45) (46) . An important factor in memory diversity is cross-reactivity, which is a function of specificity of the naive repertoire T cells (47) .
From molecular properties to repertoire statistics
A central theoretical objective is to relate the avidity spectrum to underlying cellular and molecular parameters because this would help us link therapeutic intervention at the molecular level to the desired curative effects at the systemic level.
Combining the triggering rate model (Box 2) with the statistical distribution of the mean TCR/pMHC residence time (Box 3), one can derive the statistical distribution of the MHCspecific TCR triggering rate for a given foreign pMHC ligand. A foreign ligand is a ligand to which the repertoire T cells are yet to be exposed (a self-peptide derived from the host proteome can be foreign by this definition). Graphs of this TCR triggering rate distribution are shown in Fig. 5 for various parameter values. These curves plot the probability that the given foreign ligand elicits, in a randomly selected naive T cell, a triggering rate per pMHC molecule that is at least as great as the abscissa.
Among the possibilities shown in Fig. 5 , there is a curve with a broad central plateau, indicating that probability mass is concentrated at the extremes of TCR triggering rate 0 and the maximum possible triggering rate. This particular case corresponds to the dichotomous (all-or-none) character alluded to above. Interestingly, a virtually discrete triggering rate distribution can be realized despite the intrinsically continuous nature of the underlying distribution of the off-rate (Box 3). The vertical location of the plateau (10 ÿ5 in Fig. 5) indicates the probability that a particular clonotype recognizes a randomly chosen ligand; this probability is a measure of TCR degeneracy (14) , also termed the crossreactivity parameter (48) . For other parameter combinations, the plateau exhibits a pronounced slope, which endows the Normalized MHC-specific TCR triggering rate Probability density Fig. 4 . Responder avidity spectra for various ligand presentation levels. Distribution of the normalized MHC-specific TCR triggering rate w ij T R for a given immunogenic ligand j among the responding TCR clonotypes i, as in Fig. 3 . Curves obtained for various amounts of immunogenic ligand present on the professional APCs that activate the naive T cells (numbers indicate the dose, normalized with respect to the lowest one shown). The probability mass shifts to the right as the dose decreases, indicating a more stringent selection for high-avidity clones at lower presentation levels on the professional APC.
Box 3. Statistical distribution of mean TCR/pMHC residence times Let U ij denote the dissociation energy barrier (in Boltzmann units) for the binding of a TCR molecule of clonotype i to a pMHC molecule of species j. The mean residence time of an interaction between these two species is given by the Arrhenius equation:
where f 0 is the frequency factor, which we assume independent of i or j. immune system with the opportunity to fine-tune the degeneracy of recognition. For instance, the number of clones responding to a given pathogenic challenge can be adjusted by a global (system-level) signal that induces all naive T cells in the repertoire to alter their activation threshold. Such global signals can be transmitted through cytokines. We conclude that variation in molecular parameters allows the immune system to adjust the extent to which recognition is an all-or-none phenomenon and, moreover, to tune the level of degeneracy. Thus, the system can dynamically adapt to circumstances that might, at one extreme, require highly targeted, highavidity effectors only, or, at the other extreme, a broad-spectrum polyclonal response consisting of fairly cross-reactive effectors.
Immunological tolerance as a multicomponent system Tolerance, defined as the lack of responsiveness to non-diseaseassociated antigens, is an essential feature of the immune system. Such antigens include peptides derived from the host proteome, often referred to as self. A detailed understanding of tolerance at the molecular and cellular levels is a crucial prerequisite for clinical manipulation aimed either at reinforcing tolerance to combat autoimmune disease, which develops when tolerance is lost, or to suppress tolerance for selected ligands such as tumor-associated antigens.
Tolerance is traditionally divided into central tolerance, acquired by immature lymphocytes in the central lymphoid organs (notably the thymus), and peripheral tolerance, acquired by mature lymphocytes in the peripheral tissues. From a functional point of view, one may also classify tolerance as deletional or adaptive, depending on whether self-reactive T cells are removed from the repertoire or whether they tune their responsiveness, so that self-reactivity is lost. Extreme nonresponsiveness (anergy) effectively amounts to removal from the repertoire. Moreover, such anergic cells may differentiate into regulatory T cells, whose high reactivity to non-diseaseassociated antigens plays a positive role in safeguarding tolerance (9, 49) . Although regulatory T cells are without doubt an essential component of immunological tolerance (50) , theorists were quick to rule out the necessity of such a component when the concept of regulatory T cells fell out of favor with immunologists (46) . More recently, a model of T-cell-mediated tolerance correctly predicted the inverse correlation between the infection and the incidence of autoimmune disease (51) .
Deletional tolerance can also take the form of programmed cell death (apoptosis) predicated on recognition of nondisease-associated antigens. Death of strongly self-recognizing T cells takes place in the thymus and is known as negative selection (30) . Yet virtually every selected clonotype will retain some residual avidity for several self-antigens; this residual effect is succinctly encoded in the tolerized avidity spectrum.
Tolerized avidity spectra: tolerance and ignorance are shades of gray Tolerance to a given antigen can be characterized by investigating the avidity spectrum over the T-cell repertoire for that antigen. A range of such spectra are shown in Fig. 6 . The top curve is the spectrum for an antigen against which absolutely no tolerance has been acquired; such an antigen is foreign by definition. Antigens derived from the proteome of a pathogen are almost invariably foreign in this sense. The Normalized MHC-specific TCR triggering rate Survivor Fig. 6 . Tolerance alters the triggering rate distribution. Curves represent the statistical survivor function (defined as complement of the cumulative distribution function) of w ij T R , the normalized MHCspecific TCR triggering rate. The top curve is one of the curves in Fig. 5 ; it applies for a ligand species j that has never been presented in deletional tolerization, as is typically the case for pathogen-derived ligands but may also be true for certain 'cryptic' ligands derived from the host proteome. The remaining curves apply for ligands that have been presented at various presentation levels during tolerization. A truncation point is evident; this point shifts to the left as the tolerizing presentation level increases. Normalized MHC-specific TCR triggering rate Survivor function Fig. 5 . Statistical distribution of the MHC-specific TCR triggering rate. The statistical survivor function (defined as complement of the cumulative distribution function) of w ij T R , the normalized MHCspecific TCR triggering rate, for various values of the parameters T 0 and n (see Box 3), chosen so the typical precursor probability equals 10 ÿ5 at w ij ¼ 0.2/T R for all curves. This statistical survivor curve plots the probability that the given foreign ligand elicits, in a randomly selected naive T cell, a triggering rate per pMHC molecule that is at least as great as the abscissa. The top curve in Fig. 2 remaining curves show various degrees of tolerance: a truncation at high TCR triggering rates is evident. For any given ligand, its truncation point depends on its presentation level in the thymus. The frequency with which the thymocyte encounters the ligand during central tolerization determines the degree to which the repertoire is depleted as regards avidities (this frequency is 0 for foreign ligand, and no aviditydepletion is achieved for such ligands). These theoretical results (52) predict that negative selection will tend to allow T cells with high avidity for subdominant or cryptic epitopes to persist, while effectively deleting high-avidity T cells specific for dominant epitopes. Experimental findings are in keeping with this prediction (53) . The repertoire is sometimes said to be ignorant about such cryptic epitopes. The relationships between the thymic presentation level of an antigen, its presentation level during the induction of a response, and experimental findings on avidity spectrum of the response (25) agree fully with the theoretical predictions.
An obvious clinical importance attaches to host proteomederived antigens that remain immunogenic even after tolerization, as a result of low 'immunovisibility'. When such a selfantigen is associated with proteins involved in normal physiological functions, it poses a risk for autoimmune disease (54) . As soon as the antigen becomes immunologically more 'visible', clonotypes reactive to the antigen may be expanded, leading to damage of the healthy tissue in which it is expressed. When an essentially foreign antigen derives from proteins that are expressed at high levels only in diseased cells (such as neoplastic cells), it constitutes a likely target for immune surveillance of tumors and a good candidate for so-called T-cell vaccination (55) .
An interesting corollary is that information about thymic selection is contained in the avidity spectra of the working repertoire. Comparison of an antigen's avidity spectrum with the foreign spectrum allows one to determine (i) the frequency with which T cells are exposed to that antigen during central (deletional) tolerization; as well as (ii) the typical levels at which the antigen is presented during that process. Thus, key parameters of deletional tolerance can be experimentally determined from tolerized avidity spectra across the naive repertoire.
Tuning T-cell responsiveness
To obtain an insight into adaptive tolerance, we plot the probability that a given naive T cell is activated as a function of the cellular activation threshold, obtaining an activation curve. Fig. 7 shows two such activation curves for a given T cell: one where the professional APC is presenting only harmless selfantigens and one where pathogen-derived antigens are presented as well. Marking off a maximum allowed probability of autoactivation and a minimum allowed probability of activation by the relevant ligand, we find, respectively, minimum and maximum allowed cellular activation threshold values, indicated by W min act and W max act : The business of adaptive tolerance mechanisms is to set the activation threshold to a value between these two extremes (see Box 4 for more details). Recalling the discussion surrounding the responder avidity spectra shown in Fig. 3 , we infer that the optimal cellular activation threshold lies at the upper extreme.
The difference DW ¼ W max act ÿW min act is the separation of the activation curves. With a greater separation DW, it is less likely Fig. 7 . Principle of separation of activation curves. The dashed curve represents the probability of autoactivation as a function of the cellular max activation threshold W act . The maximum allowable probability of autoactivation, P max auto ; defines a minimum allowable activation threshold W min act ; as indicated. The bold curve represents the probability of activation by an APC carrying the immunologically relevant ligand(s). The minimum allowable probability of activation, P min act ; defines a maximum allowable activation threshold W max act : The difference DW is the separation of activation curves. This separation increases as the presentation level of antigen on the APC increases. An effective immune response is possible if, at physiological presentation levels, DW is at least an order of magnitude wider than the natural variation of cellular activation levels in the T-cell repertoire.
Box 4. Dynamics of the T-cell activation threshold
We assume that the total amount W of TCR stimulation registered by a T cell is additive, that is that adaptive tolerance fails to set the cellular activation threshold to a value in between W min act and W max act : Three factors determine the separation of the activation curves: (i) the presentation levels of the foreign ligands; (ii) the presentation diversity of the pathogen-derived ligands; and (iii) the variability of the background formed by harmless selfantigens. We discuss these three factors in turn.
First, the activation curve separation DW increases with the foreign presentation levels (56) . Consequently, a minimum foreign presentation level is defined by the condition DW ¼ 0. As we saw, the responder avidity spectra (Fig. 4) bound the foreign presentation level from above; the activation curve separation principle bounds it from below. Combining these two bounds, we predict that there is a window of effective antigen presentation levels on APCs.
Second, activation curve separation decreases with the presentation diversity of the foreign antigens (57) . This diversity is defined as the Simpson's diversity index on the presentation levels. The separation DW is maximized by minimizing the foreign diversity. This provides a deep theoretical explanation for the stringent selectivity of peptide presentation on MHC molecules (57) (Box 5). We can also explain why there are several distinct MHC isoforms, with each T cell restricted to interaction with only one of these isoforms (Box 5).
Finally, activation curve separation decreases with the statistical variability of the harmless background (these fluctuations are discussed in Box 1). This result is intuitive: the noisier the background, the larger the signal has to be in order to be unequivocally detected (58) .
An intriguing result is that deletional tolerance can specifically target T cells with high self background APC-to-APC variability (59) . Such targeting requires a special relationship between self-antigen presentation statistics in the thymus and the periphery. More generally and abstractly, the relationship between thymic and peripheral presentation statistics can be said to encode the target of negative selection (this idea is made more precise in Box 6).
Discussion
The theoretical developments reviewed here elucidate and tie together numerous phenomena in the adaptive cellular immune system: epitope presentation levels, relative immunogenicity, the avidity of expanded T-cell clones, MHC isoform diversity within the individual and TCR restriction to MHC isoforms, deletional and adaptive tolerance, tuning of the T-cell activation threshold, and the functional significance of altered patterns of its molecular underpinnings (costimulation, intracellular signaling components such as kinases and phosphatases). We describe this signaling machinery as a dynamic system with state variable x(t). Moreover, let us stipulate that there is a stereotypical intrinsic cellular response threshold; for instance, a gene involved in the response is activated when the cellular concentration of the relevant transcription factor exceeds a critical value, and this value is the same for all T cells. Generally, the cellular response results when one of the state variables (which we arbitrarily take to be x 1 ) exceeds a stereotypical value k. On a time scale of minutes, the following dynamics is plausible for this 'excitation' variable:
Both F and d depend on the state of the signaling machinery x: F is the transduction function linking the TCR signal W to increase of x 1 and d represents the intensity of processes leading to decrease of x 1 (either degradation of the ' x 1 molecules' or conversion of these molecules into an inactive form). The simplest model in the general class described here has just one additional state variable x 2 with 'slow' dynamics, which allows the gain and loss terms in equation 4.2 to be adjusted to the average stimulation the T cell receives in a secondary lymphoid tissue. One example is the following system (88):
This dynamics lets x 1 fluctuate about a stereotypical baseline value (x) regardless of the average TCR signal AEWae; with x < k, activation can only ensue if a signal occurs that is significantly larger than the background average AEWae. Thus, as k represents the threshold of signaling machinery downstream from the TCR, this machinery can be identical for all T cells regardless of clonotype and input history. The slow variable x 2 represents the signal transduction gain that links the TCR signal W to the excitation variable x 1 . It can be shown that the cellular activation threshold equals kAEWae/x for this model, showing that the T-cell activation threshold is adapted to the recent TCR input history of the individual T cell.
van den Berg & Rand Á Quantitative theories of T-cell responsiveness self-antigen presentation in the thymus. As we have repeatedly pointed out, the connections expressed by theory are amenable to empirical verification; the key parameters of the theory can be determined experimentally.
Further layers of complexity We covered many aspects of T-cell responsiveness while keeping the theory as simple as possible, and many important aspects have inevitably been left out. For instance, we have ignored the crucial role of intercellular signaling in the Box 5. The MHC presentation filter An important determinant of the separation of activation curves is the Simpson's diversity of the mixture of relevant, foreign, pMHC species presented on the professional APC. As this presentation diversity increases, the two curves in Fig. 7 lie closer together, and it becomes more difficult to set the cellular activation threshold to a value that avoids autoimmunity (Box 4 discusses cellular mechanisms that set this threshold). Therefore, the risk of autoimmunity is minimized when the activation threshold is adjusted to the maximum activation curve separation achieved when foreign presentation diversity is minimal, that is only one foreign species is presented. The probability P(1) of presenting exactly one peptide is
where N foreign is the number of potential peptides in the foreign (viral) genome and p is the presentation selectivity of MHC presentation (this Poisson approximation follows from the ubiquity model, see Box 1). Probability P(1) is maximized when p ¼ 1/N foreign . This accords well with the estimate that a typical protein of approximately 400 amino acids will yield, on average, between 0.1 and 1 peptides that will bind to a given MHC isoform (27) . With the activation threshold set to respond when foreign presentation diversity is minimal, a pathogen can evade detection by increasing this diversity: the pathogen can make itself invisible by making more of its peptides presentable. The immune system circumvents this difficulty by dividing the TCR repertoire into n M parallel repertoires, each restricted to interacting with only one of the n M MHC isoforms present. The probability that the pathogen escapes detection, then decreases exponentially with n M (32, 89, 90) :
ð5:2Þ
Restriction of TCR recognition to a single MHC isoform is required to preserve the maximum separation of activation curves. In sum, the phenomena of MHC presentation selectivity, MHC isoform diversity within the individual, and MHC restriction all stem from the principle of separation of activation curves.
Box 6. Thymic antigen presentation determines how negative selection shapes the TCR repertoire Stringent intrinsic bounds on thymic presentation statistics preclude negative selection from fully eradicating TCR autoreactivity (91) . Some autoreactivity unavoidably remains after negative selection. How can we quantify this residual autoreactivity?
We start by observing that a TCR clonotype i is fully specified by
; the MHC-specific TCR triggering rates for all pMHC species j (equation 2.2). Let the parameter vector q lymph characterizes the statistics of antigen presentation in the secondary lymphoid tissue and consider a function X of w i and q lymph , such that x i ¼ X(w i , q lymph ) resents a statistical property of autorecognition by clonotype i. The effect of thymic selection (deletional tolerance) on the statistical structure of the TCR repertoire as regards property X can then be expressed as follows:
where q thymus characterizes the statistics of antigen presentation on negatively selecting APCs in the thymus and S X is a selection function that expresses how strongly property X is affected by thymic selection. If we know q lymph and q thymus , we can determine which properties X are most strongly affected by selection. Conversely, given a property X and statistics q lymph , we can determine q thymus such that S X is large (for a certain range of x values). For instance, it can be shown (59) that the choice q thymus ¼ q lymph strongly selects against thymocytes that would register, if allowed to mature into naive T cells, a large average self-stimulation in the secondary lymphoid tissues. By contrast, strong selection against the variability of the selfsignal (registered over different APCs) occurs when propensity and ubiquity (see for every pair of self-antigens j and j# (thy, thymus and lym, secondary lymphoid tissues).
van den Berg & Rand Á Quantitative theories of T-cell responsiveness orchestrated evolution of the immune response, which has been extensively modeled (60) (61) (62) (63) . Most notably, we have neglected the evolution of dedicated receptor interaction zones within the T cell:APC contact area, in which the kinase/phosphatase balance is drastically altered (64) (65) (66) (67) . We think of the TCR/CD3 complex as a bistable system that is normally stably locked in the untriggered 'ground' state by negative regulatory interactions (68) and, provided the pMHC/TCR interaction lasts longer than the threshold duration T R , becomes locked into the signaling state, which is similarly stabilized by positive interactions (29) . We have assumed that the TCR quickly reverts to the untriggered state if the triggered state is not attained; this assumption may be false in phosphatase-depleted zones of the contact area, where the TCR would revert slowly, allowing subsequent interactions with distinct ligand molecules to contribute to the triggering of a given TCR/CD3 complex (69) . To model this situation, intermediate states of TCR/CD3 phosphorylation must be taken into account (70, 71) . Detailed computational models of immune receptor signaling machinery are reviewed elsewhere (72) . A key enzyme in the transition of the TCR from the untriggered to the triggered state is Lck, a kinase that phosphorylates specific intracellular components of the TCR/CD3 complex and whose activation state exhibits bistability (68) . TCR bistability (untriggered/ triggered) interacts with Lck bistability (inactive/active), leading to non-linear dynamics (73, 74) . Another aspect is the role of the coreceptor, which stabilizes the TCR/pMHC interaction and thus modulates T ij (75) and may also profoundly affect the receptor threshold T R , for instance, by modulating its recruitment to kinase-rich membrane microdomains (76) (77) (78) (79) .
Conclusions
Immunologists are traditionally perhaps most comfortable with the concept of affinity, but TCR recognition raises many perplexities when addressed in terms of affinity: it may seem paradoxical that TCR recognition achieves such exquisite ligand discrimination when even potent interactions have very low biochemical affinity, and one may wonder how affinity-based selection of a TCR repertoire is possible at all. As the theoretical developments reviewed here show, such questions really are red herrings. This becomes clear once one realizes the key parameter to focus on is avidity, represented here in terms of the TCR triggering rate. This quantity depends primarily on the mean TCR/pMHC dwell time, while it is modulated by the dissociation constant (i.e. affinity) and combines with antigen presentation levels to produce additive multiple-site effects (Box 2). Moreover, mathematical immunology now affords an integrated understanding of immune tolerance, response efficiency, and MHC restriction by considering statistical distributions of avidity, across the naive repertoire and across the set of responders to a given pathogenic challenge.
